NCT01658839 Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients Status COMPLETED Phase PHASE1
NCT01639807 Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP Status UNKNOWN Phase NA
NCT01621841 Analysis of Visual Pathways in Glaucoma Patients Using a 3tesla-MRI Status COMPLETED Phase N/A
NCT01592955 Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU) Status COMPLETED Phase PHASE4
NCT01544192 Impact of Oral Versatile Antioxidants on Glaucoma Progression Status COMPLETED Phase PHASE3
NCT01535768 Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves Status UNKNOWN Phase PHASE4
NCT01525173 A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension Status COMPLETED Phase PHASE4
NCT01518244 Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America Status COMPLETED Phase PHASE4
NCT01514734 Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil Status TERMINATED Phase PHASE4
NCT01514721 Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy Status TERMINATED Phase PHASE4
NCT01495312 24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT) Status WITHDRAWN Phase NA
NCT01495299 24-hour IOP Fluctuation Profile Recorded With SENSIMED Triggerfish in Primary Open-angle Glaucoma (POAG) Patients After Cataract Surgery Status WITHDRAWN Phase N/A